| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.092 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |